Lawton Alison Frances
SEC insider (Form 3/4/5 filer). CIK 0001542650. Director at Dianthus Therapeutics, Inc. /DE/ (DNTH) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in LEIDEN.
Companies Lawton Alison Frances has filed insider reports for
- Dianthus Therapeutics, Inc. /DE/ (DNTH): Director
- ProQR Therapeutics N.V. (PRQR): Director
Lawton Alison Frances
CIK: 0001542650
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
